Education
About Us
Working with TipRanks
Follow Us
MeVis Medical Solutions AG (DE:M3V)
XETRA:M3V
Total Valuation
MeVis Medical Solutions has a market cap or net worth of €44.41M. The enterprise value is €37.52M.
Market Cap€44.41M
Enterprise Value€37.52M
Share Statistics
MeVis Medical Solutions has 1,820,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,820,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MeVis Medical Solutions’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 11.21%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)11.21%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee160.61K
Profits Per Employee31.66K
Employee Count100
Asset Turnover0.62
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MeVis Medical Solutions is 14.0. MeVis Medical Solutions’s PEG ratio is -0.46.
PE Ratio14.0
PS Ratio2.81
PB Ratio2.53
Price to Fair Value2.53
Price to FCF12.07
Price to Operating Cash Flow0.00
PEG Ratio-0.46
Income Statement
In the last 12 months, MeVis Medical Solutions had revenue of 16.06M and earned 3.17M in profits. Earnings per share was 1.74.
Revenue16.06M
Gross Profit15.69M
Operating Income2.34M
Pretax Income3.28M
Net Income3.17M
EBITDA3.43M
Earnings Per Share (EPS)1.74
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
MeVis Medical Solutions pays an annual dividend of €0.95, resulting in a dividend yield of 3.86%
Dividend Per Share€0.95
Dividend Yield3.86%
Payout Ratio40.17%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change-1.19%
50-Day Moving Average24.92
200-Day Moving Average25.07
Relative Strength Index (RSI)35.09
Average Volume (3m)99.00
Important Dates
MeVis Medical Solutions upcoming earnings date is Jun 1, 2026, TBA (Confirmed).
Last Earnings DateJan 29, 2026
Next Earnings DateJun 1, 2026
Ex-Dividend Date―
Financial Position
MeVis Medical Solutions as a current ratio of 1.58, with Debt / Equity ratio of 0.00%
Current Ratio1.58
Quick Ratio1.58
Debt to Market Cap0.00
Net Debt to EBITDA-1.90
Interest Coverage Ratio4.06K
Taxes
In the past 12 months, MeVis Medical Solutions has paid 113.00K in taxes.
Income Tax113.00K
Effective Tax Rate0.03
Enterprise Valuation
MeVis Medical Solutions EV to EBITDA ratio is 11.27, with an EV/FCF ratio of 10.33.
EV to Sales2.40
EV to EBITDA11.27
EV to Free Cash Flow10.33
EV to Operating Cash Flow9.95
Balance Sheet
MeVis Medical Solutions has €2.57M in cash and marketable securities with €0.00 in debt, giving a net cash position of €2.57M billion.
Cash & Marketable Securities€2.57M
Total Debt€0.00
Net Cash€2.57M
Net Cash Per Share€1.41
Tangible Book Value Per Share€9.79
Margins
Gross margin is 35.37%, with operating margin of 14.58%, and net profit margin of 19.71%.
Gross Margin35.37%
Operating Margin14.58%
Pretax Margin20.41%
Net Profit Margin19.71%
EBITDA Margin21.33%
EBIT Margin20.42%
Analyst Forecast
The average price target for MeVis Medical Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.72%
EPS Growth Forecast-25.19%